AVLN
Avalyn Pharma Inc.Company with tickers: AVLN
CIK
1540171
CUSIP
05348Y105
Shares Outstanding
44,333,095
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Buy | 277,778 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 872,868 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 9,418,561 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 377,948 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Other | 25,899,284 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 489,486 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 80,291 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Other | 12,558,081 |
| 2026-05-01 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. |
10% Owner | Other | 20,482,289 |
| 2026-05-01 | Carroll Jill |
Director | Buy | 277,778 |
| 2026-05-01 | Carroll Jill |
Director | Other | 9,418,561 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Other | 5,587,603 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Other | 3,327,734 |
| 2026-05-01 | Carroll Jill |
Director | Other | 489,486 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 727,585 |
| 2026-05-01 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. |
10% Owner | Other | 4,060,259 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Other | 1,986,369 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 80,291 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 1,419,298 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 27,309,719 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 489,486 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 377,948 |
| 2026-05-01 | Carroll Jill |
Director | Other | 1,419,298 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Other | 18,000,000 |
| 2026-05-01 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. |
10% Owner | Other | 1,275,486 |
| 2026-05-01 | Carroll Jill |
Director | Other | 27,309,719 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 354,824 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 225,843 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 872,868 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 727,585 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 6,827,429 |
| 2026-05-01 | FMR LLC |
10% Owner | Other | 225,843 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 9,418,560 |
| 2026-05-01 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Buy | 277,777 |
| 2026-05-01 | Novo Holdings A/S |
10% Owner | Buy | 555,555 |
| 2026-04-30 | Lavelle Erin |
COO & CFO | Award | 26,978 |
| 2026-04-30 | Carlson Douglas R |
COO & EVP of Finance | Award | 211,975 |
| 2026-04-29 | Baranowski Lyn |
Director | Other | 0 |
| 2026-04-29 | Golden Adam H. |
General Counsel | Other | 0 |
| 2026-04-29 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 0 |
| 2026-04-29 | Congleton Jon |
Director, Chief Executive Officer | Other | 0 |
| 2026-04-29 | SR ONE CAPITAL MANAGEMENT, LLC |
10% Owner | Other | 0 |
| 2026-04-29 | Carroll Jill |
Director | Other | 0 |
| 2026-04-29 | FMR LLC |
10% Owner | Other | 0 |
| 2026-04-29 | Novo Holdings A/S |
10% Owner | Other | 0 |
| 2026-04-29 | Novo Holdings A/S |
10% Owner | Other | 0 |
| 2026-04-29 | FMR LLC |
10% Owner | Other | 0 |
| 2026-04-29 | Turner Heather D |
Director | Award | 26,978 |
| 2026-04-29 | Novo Holdings A/S |
10% Owner | Other | 0 |
| 2026-04-29 | Golden Adam H. |
General Counsel | Award | 254,891 |
Showing 1–50 of 78 transactions